The Institute

Research centre for cancer, neurosciences and translational medicine

The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center established in 2004. Its stakeholders are Bellvitge University Hospital and Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, University of Barcelona and the town council of L’Hospitalet de Llobregat.

IDIBELL is located in L’Hospitalet de Llobregat, south of Barcelona. It is a member of the Campus of International Excellence of the University of Barcelona HUBc and part of the CERCA institution of the Generalitat of Catalonia. In 2009, it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Institute of Health.

A key aspect of research in IDIBELL is its proximity to the patient. Because of its location and the healthcare activity that many of its researchers carry out, IDIBELL research groups can identify which problems are really priority and which solutions are effective in daily clinical practice.

A privileged area

IDIBELL is located in the Bellvitge Campus area, a biomedical and biotechnology cluster of health care facilities, knowledge-generating institutions, research centres and companies of the sector of life sciences and health in constant growth; an area that is becoming one of the most dynamic and innovative places in the country in terms of health and biomedical research.

The Bellvitge Institute of Biomedical Research (IDIBELL) is a research center of cellular medicine, where the high level basic research focuses and works on relevant clinical matters and the economic development.

IDIBELL is a foundation created in 2004 from the fusion of several research entities: the Bellvitge University Hospital, the Institut Català d’Oncologia (Catalan Institute of Oncology), the University of Barcelona and the Institute of Image Diagnosis. The Institute is integrated in the health park of L’Hospitalet, known as Biopol’H.

The main scientific partners of the foundation are the University of Barcelona, the Institut Català d’Oncologia (Catalan Institute of Oncology), and the ICS (Catalan Institute of the Health) represented by the Bellvitge University Hospital.

Since the month of March of 2009, it has become one of the five Spanish research centers accredited as institute of sanitary research by the Instituto de Salud Carlos III (Health Institute Carlos III).

The Bellvitge Institute of Biomedical Research is placed in the town of L'Hospitalet de Llobregat, in the south of Barcelona. Its facilities are distributed among the Duran Hospital i Reynals, the Bellvitge University Hospital and the buildings belonging to the campus of the University of Barcelona in Bellvitge. They are all integrated in the before mentioned project Biopol.

A fundamental aspect of the research carried out in IDIBELL is its proximity to the sick person. For its situation and for the daily welfare activity that many of the IDIBELL researchers develop, it is easier to acknowledge which problems are really priority and which solutions are effective in the daily clinical practice